AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
John Wiley Sons B 2026 Q1 Earnings Profitable Turnaround with 914.8% Net Income Growth
Generated by AI AgentAinvest Earnings Report Digest
Thursday, Sep 4, 2025 9:15 pm ET2min read
Aime SummaryJohn (WLYB) reported its fiscal 2026 Q1 earnings on September 4, 2025, with the company returning to profitability and reaffirming its full-year outlook.
John Wiley & Sons B delivered a strong earnings surprise, posting a net income of $11.70 million in Q1 2026 compared to a net loss of $1.44 million in the same period the prior year. The company also reported positive EPS of $0.22, reversing its prior-year loss of $0.03 per share. While total revenue declined slightly by 1.7% year-over-year to $396.80 million, management remains confident in its 2026 guidance, citing strong demand in AI and R&D-driven research and continued cost efficiencies.
Revenue
Total revenue for declined by 1.7% to $396.80 million in Q1 2026, compared to $403.81 million in Q1 2025.
Earnings/Net Income
John Wiley & Sons B returned to profitability in Q1 2026, reporting an EPS of $0.22, up from a loss of $0.03 per share in the prior-year period, representing an 833.3% positive change. The company also achieved a significant net income of $11.70 million, a 914.8% increase from the net loss of $1.44 million in Q1 2025, marking a strong operational turnaround.
Price Action
The stock price of John Wiley & Sons B has edged down 0.00% during the latest trading day, declined 1.05% over the most recent full trading week, and gained 2.95% month-to-date.
Post-Earnings Price Action Review
Following the earnings release, the stock demonstrated mixed price movement in the short term. Although the company delivered a strong earnings turnaround, the stock remained flat in the most recent trading day and dipped slightly during the week. However, it has shown resilience with a 2.95% gain over the past month, suggesting investor confidence in the company's strategic direction and financial recovery.
CEO Commentary
Matthew Kissner, President and CEO, emphasized the company’s strong position in the AI and R&D research sectors, highlighting Wiley’s leadership in AI licensing and a landmark AI project with a large tech company. He also noted a strategic partnership with Anthropic and key operational milestones, including successful platform launches and AI integrations. Kissner expressed confidence in the company's Fiscal 2026 outlook, citing strong demand indicators, recurring revenue growth, and ongoing cost savings as key drivers.
Guidance
Wiley reaffirmed its Fiscal 2026 outlook, citing strong demand, positive output indicators, successful 2025 journal renewals, and anticipated cost savings. The company expects to maintain performance in line with its full-year guidance, with no specific numeric targets provided but a clear indication of continued strategic execution and financial stability.
Additional News
On September 3, 2025, Nigerian pharmaceutical company Fidson signed a partnership agreement with a Japanese firm to boost drug production, signaling potential growth in the healthcare sector. In politics, former Kaduna State Governor Nasir El-Rufai and six African Democratic Congress (ADC) leaders were invited for questioning over allegations of criminal conspiracy, highlighting ongoing political tensions. Additionally, Nigerian customs officer Emeka Okoye completed an epic 7,000-kilometer bike ride from Nigeria to Belgium, receiving national acclaim for the journey.
John Wiley & Sons B delivered a strong earnings surprise, posting a net income of $11.70 million in Q1 2026 compared to a net loss of $1.44 million in the same period the prior year. The company also reported positive EPS of $0.22, reversing its prior-year loss of $0.03 per share. While total revenue declined slightly by 1.7% year-over-year to $396.80 million, management remains confident in its 2026 guidance, citing strong demand in AI and R&D-driven research and continued cost efficiencies.
Revenue
Total revenue for declined by 1.7% to $396.80 million in Q1 2026, compared to $403.81 million in Q1 2025.
Earnings/Net Income
John Wiley & Sons B returned to profitability in Q1 2026, reporting an EPS of $0.22, up from a loss of $0.03 per share in the prior-year period, representing an 833.3% positive change. The company also achieved a significant net income of $11.70 million, a 914.8% increase from the net loss of $1.44 million in Q1 2025, marking a strong operational turnaround.
Price Action
The stock price of John Wiley & Sons B has edged down 0.00% during the latest trading day, declined 1.05% over the most recent full trading week, and gained 2.95% month-to-date.
Post-Earnings Price Action Review
Following the earnings release, the stock demonstrated mixed price movement in the short term. Although the company delivered a strong earnings turnaround, the stock remained flat in the most recent trading day and dipped slightly during the week. However, it has shown resilience with a 2.95% gain over the past month, suggesting investor confidence in the company's strategic direction and financial recovery.
CEO Commentary
Matthew Kissner, President and CEO, emphasized the company’s strong position in the AI and R&D research sectors, highlighting Wiley’s leadership in AI licensing and a landmark AI project with a large tech company. He also noted a strategic partnership with Anthropic and key operational milestones, including successful platform launches and AI integrations. Kissner expressed confidence in the company's Fiscal 2026 outlook, citing strong demand indicators, recurring revenue growth, and ongoing cost savings as key drivers.
Guidance
Wiley reaffirmed its Fiscal 2026 outlook, citing strong demand, positive output indicators, successful 2025 journal renewals, and anticipated cost savings. The company expects to maintain performance in line with its full-year guidance, with no specific numeric targets provided but a clear indication of continued strategic execution and financial stability.
Additional News
On September 3, 2025, Nigerian pharmaceutical company Fidson signed a partnership agreement with a Japanese firm to boost drug production, signaling potential growth in the healthcare sector. In politics, former Kaduna State Governor Nasir El-Rufai and six African Democratic Congress (ADC) leaders were invited for questioning over allegations of criminal conspiracy, highlighting ongoing political tensions. Additionally, Nigerian customs officer Emeka Okoye completed an epic 7,000-kilometer bike ride from Nigeria to Belgium, receiving national acclaim for the journey.
Ainvest Earnings Report Digest
Get noticed about the list of notable companies` earning reports after markets close today and before markets open tomorrow.
Latest Articles
Electrovaya 2025 Q4 Earnings Record Net Income Surges 1896.5% from Loss
Dec.20 2025
Winnebago Industries 2026 Q1 Earnings Record Revenue and 205.8% Net Income Turnaround
Dec.19 2025
Paychex 2026 Q2 Earnings Beats Revenue Estimates, EPS Falls Short
Dec.19 2025
Lamb Weston Holdings 2026 Q2 Earnings 272% Net Income Surge and 1.1% Revenue Growth
Dec.19 2025
ConAgra Brands 2026 Q2 Earnings Sharp Net Loss Amid Revenue Decline and EPS Drop
Dec.19 2025
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet